Cleveland BioLabs Annual Meeting Update
April 04 2007 - 2:09PM
PR Newswire (US)
Date Change to June 12 CLEVELAND, April 4 /PRNewswire-FirstCall/ --
Cleveland BioLabs, Inc. (NASDAQ:CBLI)(BSE:CFB), today announced
that the Company will hold its 2007 annual stockholders meeting on
June 12, 2007 at 10:00 a.m. EDT at the Intercontinental Hotel in
Cleveland, Ohio. The Company will distribute proxy materials to all
stockholders of record as of April 17, 2007. About Cleveland
BioLabs, Inc. Cleveland BioLabs, Inc. is a drug discovery and
development company leveraging its proprietary discoveries about
programmed cell death to treat cancer and protect normal tissues
from exposure to radiation and other stresses. The Company has
strategic partnerships with the Cleveland Clinic Foundation,
Roswell Park Cancer Institute, ChemBridge Corporation and the Armed
Forces Research Radiobiology Institute. To learn more about
Cleveland BioLabs Inc., please visit the company's website at
http://www.cbiolabs.com/. This press release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements reflect management's current expectations, as of the
date of this press release, and involve certain risks and
uncertainties. Our actual results could differ materially from
those anticipated in these forward-looking statements as a result
of various factors. Some of the factors that could cause future
results to materially differ from the recent results or those
projected in forward-looking statements include the "Risk Factors"
described in our filings with the Securities and Exchange
Commission. Contact: The Global Consulting Group Rachel Levine T:
(646) 284-9439 E: DATASOURCE: Cleveland BioLabs, Inc. CONTACT:
Rachel Levine of The Global Consulting Group, +1-646-284-9439, or ,
for Cleveland BioLabs, Inc. Web site: http://www.cbiolabs.com/
Copyright